Moberg Pharma has secured exercise of warrants and entered into a top guarantee free of charge
Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) has today received subscription intentions, subscription commitments and top guarantee commitments totaling approximately SEK 113.5 million, related to the warrants of series 2023:1 (“TO 2”), from a few external professional investors and the Company's largest shareholder, Östersjöstiftelsen (The Baltic Sea Foundation).”When we designed the rights issue of units last summer, the goal was to raise approximately SEK 200 million, half of which through the TO 2 warrants. The subscription commitments and the top guarantee mean that the